We have previously observed significant elevations of PG(22:6/22:6) in an MYC-driven mouse model of renal cell carcinoma that relies on a kidney-specific promoter with a tetracycline responsive element19 and a mouse lung cancer model where RAS is conditionally expressed in the lung epithelium. The gene discussed is MYC; the disease is hereditary clear cell renal cell carcinoma.